Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80090647

Market status:

Not Marketed

Licence Status:

Active

Brand name(s):

Joints First ;
Health First Joints First Capsules

Licence holder:

Health First Network

Dosage Form:

Capsule

Recommended route of administration:

Oral

Recommended use or purpose:

A factor in maintaining healthy cartilage. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee.

Risk Information:

Cautions and Warnings 

If you have a gastrointestinal lesion/ ulcer, are taking an anticoagulant/ blood thinner, anti-inflammatory or antibiotic, or are having surgery, consult a health care practitioner prior to use. Consult a health care practitioner if symptoms persist or worsen If you experience gastrointestinal symptoms such as nausea, vomiting, abdominal pain, dyspepsia, heartburn or diarrhea, discontinue use and consult a health care practitioner. If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use. If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking anticoagulant or antihypertensive medication. Consult a health care practitioner prior to use if you suffer from an immune disorder (e.g. Crohn's disease, myastenia gravis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, HIV/AIDS, etc.) cancer, asthma, are taking immunosuppresants or have severe allergies.

Contra-Indications 

If you are allergic to acetylsalicylic acid (ASA) or other salicylates, do not use this product. If you are pregnant or breastfeeding, do not use this product. Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.

Known Adverse Reactions 

Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use. Some people may experience sore mouth or mouth ulcers; in which case, dicontinue use.

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
2-Amino-2-deoxy-D-glucose sulfate	150.0 milligrams
2-Amino-2-deoxy-beta-D-glucopyranose hydrochloride	150.0 milligrams
Boswellia serrata	60.0 milligrams		65.0   % Boswellic acids
Harpagophytum procumbens	15.0 milligrams
Hydrolyzed collagen type II	30.0 milligrams
Salix alba	25.0 milligrams
Smilax officinalis	15.0 milligrams	4.0 : 1.0 DHE: 60.0 milligrams Dry
Stem bromelain	20.0 milligrams 180000.0 FCC PU
Tanacetum parthenium	10.0 milligrams
Yucca schidigera	15.0 milligrams

List of non-medicinal ingredients:

• Colloidal silicon dioxide
• Gelatin
• Magnesium stearate
• Purified water

Date of licensing:

2019-02-17

Revised date of licence: